FDA Inspection 1125294 — UCSF Radiopharmaceutical Facility
The FDA completed an inspection of UCSF Radiopharmaceutical Facility on July 24, 2020 in San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 24, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- San Francisco, CA (United States)